Highbridge Capital Management’s Omega Protein OME Stock Holding History

Highbridge Capital Management’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-22,062	Closed	-$441K	–	1860
2016 Q2	$441K	Buy	22,062 +8,329	+61%	+$155K	0.01%	896
2016 Q1	$233K	Sell	13,733 -6,227	-31%	-$128K	﹤0.01%	1276
2015 Q4	$443K	Buy	+19,960	New	+$416K	0.01%	1040
2014 Q3	–	Sell	-29,833	Closed	-$408K	–	1467
2014 Q2	$408K	Buy	29,833 +8,896	+42%	+$116K	0.01%	788
2014 Q1	$253K	Sell	20,937 -44,866	-68%	-$514K	﹤0.01%	906
2013 Q4	$808K	Sell	65,803 -105,041	-61%	-$1.23M	0.01%	577
2013 Q3	$1.74M	Sell	170,844 -24,558	-13%	-$230K	0.02%	543
2013 Q2	$1.75M	Buy	+195,402	New	+$1.97M	0.02%	521

Other funds holding OME

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JIR

James Investment Research Alpha, Ohio $891M AUM 30.4% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Highbridge Capital Management's OME Position: Q3 2016 in Review

Highbridge Capital Management sold out of Omega Protein (OME) in Q3 2016, closing a stake of 22,062 shares — an estimated $441K sold.

Highbridge Capital Management first reported a position in OME in Q2 2013 and held it in 8 quarters. The position peaked at $1.75M in Q2 2013. 155 funds tracked by Wall St. Rank hold OME as of Q3 2016.

Highbridge Capital Management reported no remaining Omega Protein position as of Q3 2016 after selling out during the quarter.
Highbridge Capital Management sold 22,062 Omega Protein shares in Q3 2016, an estimated $441K.
Highbridge Capital Management first reported a position in Omega Protein in Q2 2013 and held it in 8 quarters.
Highbridge Capital Management's Omega Protein position peaked at $1.75M in Q2 2013.
155 funds tracked by Wall St. Rank held Omega Protein as of Q3 2016.

Based on Highbridge Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.